Removing Obstacles In Radiopharmaceutical Studies

By Sue Batchelor, Director, Clinical Operations and Delivery

Radiopharmaceutical (RP) studies are not your average clinical trial. For me, running these trials feels very similar to developing highly sophisticated recipes. If you like your trial meaty, with complex deep flavours and a sprinkling of chilli, you’ve found your ideal dish!

With the RP space expanding, Sponsors are looking for teams with the experience it takes to turn their synopsis into a fully rounded protocol with the maximum chance of success. Each element of RP research requires detailed consideration, planning and management. Isotope selection (lutecium, radio copper, etc), compounding method (central, local or homebrew) and administration routes are a few examples of these elements.

I feel very lucky to lead a team that can bring all elements together, ensuring the research and medical considerations match the capabilities and local processes at site, using our Nuclear Medicine departmental experience. Like Mise en Place, we dedicate the time it takes to plan and set up the study.